Advanced Search
Submit Manuscript Volume 29, No 5, May 2019
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 29 Issue 5, May 2019: 347-364 |
Daolin Tang 1,2 , Rui Kang2 , Tom Vanden Berghe 3,4,5 , Peter Vandenabeele 3,4,6 and Guido Kroemer 7,8,9,10,11,12,13
1 The Third Affiliated Hospital, Protein Modification and Degradation Lab, School of Basic Medical Sciences, Guangzhou Medical University, 510510 Guangzhou, Guangdong,China; 2 Department of Surgery, UT Southwestern Medical Center, Dallas, TX 75390, USA; 3Molecular Signaling and Cell Death Unit, VIB-UGent Center for Inflammation Research,Flanders Institute for Biotechnology, 9052 Ghent, Belgium; 4Department for Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium; 5Laboratory of Pathophysiology, Faculty of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium; 6Methusalem program, Ghent University, 9000 Ghent, Belgium; 7Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France; 8Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France; 9Institut National de la Santé et de la Recherche Médicale, U1138 Paris, France; 10 Université Pierre et Marie Curie, 75006 Paris, France; 11 Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France; 12 Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, 75015 Paris, France and 13 Department of Women’s and Children’s Health, Karolinska University Hospital, 17176 Stockholm, Sweden
https://doi.org/10.1038/s41422-019-0164-5